Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411315 · ClinicalTrials.gov registry record · NA
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 700
- Enrollment target
NCT05411315 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 700 participants.
The verdict
NCT05411315, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
Study Summary
Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.
Interventions
- OTHER Restricted-use of arterial catheter
- OTHER Standard-use of arterial catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2023-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05411315
The ClinicalTrials.gov registry entry for NCT05411315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restricted-use of arterial catheter is the first listed.
NCT05411315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05411315 about?
NCT05411315 is a clinical study titled "Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment". Investigators will conduct a pragmatic randomized trial to investigate the non-inferiority of restricted use of invasive arterial lines compared to standard arterial line use.
What is the current status of trial NCT05411315?
This trial is currently completed. It is a NA study. The enrollment target is 700 participants. The study started on 2022-10-17. Estimated completion is 2023-07-14.
What interventions are being tested in trial NCT05411315?
The interventions under investigation include: Restricted-use of arterial catheter (OTHER), Standard-use of arterial catheter (OTHER).
Who is sponsoring clinical trial NCT05411315?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.